Bloodstream Infection: Current Challenges and Therapeutic Strategies
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 31 December 2026 | Viewed by 424
Special Issue Editors
Interests: antimicrobial stewardship; antimicrobial resistance; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Interests: antibiotics; synergism; pharmacokinetic; Clostridioides difficile; antimicrobial stewardship
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bloodstream infections (BSIs) represent a high morbidity and high mortality disease state that requires prompt antimicrobial therapy. Robust antimicrobial stewardship programs and novel strategies have been implemented to improve the care of patients with BSIs. While there has been an influx of recent literature concerning the management of BSIs, a need to further optimize therapy to improve outcomes and reduce adverse events associated with antimicrobial therapy remains.
This Special Issue aims to provide a comprehensive update on novel or adapted strategies for the management of patients with BSIs. Manuscripts describing therapeutic and antimicrobial stewardship strategies for the treatment of BSIs will be considered for publication. We welcome original research articles, reviews, or meta-analyses that address the aforementioned considerations. I hope you will consider submitting your work to this Special Issue of Antibiotics.
Dr. Daniel T. Anderson
Dr. Stefano Di Bella
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bloodstream infection
- antimicrobial stewardship
- antimicrobial resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
